Literature DB >> 20934487

Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models.

Y Y Li1, J G Cui, J M Hill, S Bhattacharjee, Y Zhao, W J Lukiw.   

Abstract

A mouse and human brain-enriched micro-RNA-146a (miRNA-146a) is known to be important in modulating the innate immune response and inflammatory signaling in certain immunological and brain cell types. In this study we examined miRNA-146a levels in early-, moderate- and late-stage Alzheimer's disease (AD) neocortex and hippocampus, in several human primary brain and retinal cell lines, and in 5 different transgenic mouse models of AD including Tg2576, TgCRND8, PSAPP, 3xTg-AD and 5xFAD. Inducible expression of miRNA-146a was found to be significantly up-regulated in a primary co-culture of human neuronal-glial (HNG) cells stressed using interleukin1-beta (IL-1β), and this up-regulation was quenched using specific NF-кB inhibitors including curcumin. Expression of miRNA-146a correlated with senile plaque density and synaptic pathology in Tg2576 and in 5xFAD transgenic mouse models used in the study of this common neurodegenerative disorder.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934487      PMCID: PMC5382794          DOI: 10.1016/j.neulet.2010.09.079

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  30 in total

1.  Clinicopathological analysis of dementia disorders in the elderly--an update.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

Review 2.  MicroRNA-146a and human disease.

Authors:  L Li; X-P Chen; Y-J Li
Journal:  Scand J Immunol       Date:  2010-04       Impact factor: 3.487

3.  Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.

Authors:  Samir Kumar-Singh; Daniel Pirici; Eileen McGowan; Sally Serneels; Chantal Ceuterick; John Hardy; Karen Duff; Dennis Dickson; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 4.  Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.

Authors:  Gunnar K Gouras; Davide Tampellini; Reisuke H Takahashi; Estibaliz Capetillo-Zarate
Journal:  Acta Neuropathol       Date:  2010-03-31       Impact factor: 17.088

5.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

Review 6.  Probing the biology of Alzheimer's disease in mice.

Authors:  Karen H Ashe; Kathleen R Zahs
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

7.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.

Authors:  L Holcomb; M N Gordon; E McGowan; X Yu; S Benkovic; P Jantzen; K Wright; I Saad; R Mueller; D Morgan; S Sanders; C Zehr; K O'Campo; J Hardy; C M Prada; C Eckman; S Younkin; K Hsiao; K Duff
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

Review 8.  Animal models of amyloid-beta-related pathologies in Alzheimer's disease.

Authors:  Ola Philipson; Anna Lord; Astrid Gumucio; Paul O'Callaghan; Lars Lannfelt; Lars N G Nilsson
Journal:  FEBS J       Date:  2010-02-03       Impact factor: 5.542

9.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

10.  A miRNA signature of prion induced neurodegeneration.

Authors:  Reuben Saba; Chelsey D Goodman; Rhiannon L C H Huzarewich; Catherine Robertson; Stephanie A Booth
Journal:  PLoS One       Date:  2008-11-06       Impact factor: 3.240

View more
  64 in total

1.  NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells.

Authors:  Walter J Lukiw
Journal:  Exp Neurol       Date:  2011-11-23       Impact factor: 5.330

2.  Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD).

Authors:  Walter J Lukiw; Bhattacharjee Surjyadipta; Prerna Dua; Peter N Alexandrov
Journal:  Int J Biochem Mol Biol       Date:  2012-03-20

3.  Copper-Induced Upregulation of MicroRNAs Directs the Suppression of Endothelial LRP1 in Alzheimer's Disease Model.

Authors:  Heng-Wei Hsu; Carlos J Rodriguez-Ortiz; Siok Lam Lim; Joannee Zumkehr; Jason G Kilian; Janielle Vidal; Masashi Kitazawa
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

4.  Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease.

Authors:  Peter N Alexandrov; Aileen Pogue; Surjyadipta Bhattacharjee; Walter J Lukiw
Journal:  Neuroreport       Date:  2011-08-24       Impact factor: 1.837

Review 5.  Pathway analysis of the human brain transcriptome in disease.

Authors:  Tomas Kavanagh; James D Mills; Woojin S Kim; Glenda M Halliday; Michael Janitz
Journal:  J Mol Neurosci       Date:  2012-12-22       Impact factor: 3.444

Review 6.  Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.

Authors:  Amir Abbas Momtazi; Giuseppe Derosa; Pamela Maffioli; Maciej Banach; Amirhossein Sahebkar
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

7.  Upregulation of miR-181 decreases c-Fos and SIRT-1 in the hippocampus of 3xTg-AD mice.

Authors:  Carlos J Rodriguez-Ortiz; David Baglietto-Vargas; Hilda Martinez-Coria; Frank M LaFerla; Masashi Kitazawa
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

9.  Peripheral Blood MicroRNA Expression Profiles in Alzheimer's Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism.

Authors:  Ru-Jing Ren; Yong-Fang Zhang; Eric B Dammer; Yi Zhou; Li-Ling Wang; Xiao-Hong Liu; Bei-Lei Feng; Guo-Xin Jiang; Sheng-Di Chen; Gang Wang; Qi Cheng
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

Review 10.  Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology.

Authors:  Melvyn J Ball; Walter J Lukiw; Eli M Kammerman; James M Hill
Journal:  Alzheimers Dement       Date:  2012-11-14       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.